Editorial Comment to External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients

Affiliations

Editorial

Koichiro Akakura. Int J Urol. 2022 Jan.

. 2022 Jan;29(1):24-25.

doi: 10.1111/iju.14723. Epub 2021 Oct 4.

¹ Department of Urology, Japan Community Health-Care Organization, Tokyo Shinjuku Medical Center, Tokyo, Japan.

No abstract available

Comment on

External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients.
Würnschimmel C, Wenzel M, Chierigo F, Flammia RS, Tian Z, Saad F, Briganti A, Shariat SF, Suardi N, Terrone C, Gallucci M, Chun FK, Tilki D, Graefen M, Karakiewicz PI. Würnschimmel C, et al. Int J Urol. 2022 Jan;29(1):17-24. doi: 10.1111/iju.14701. Epub 2021 Sep 22. Int J Urol. 2022. PMID: 34553428

1. Würnschimmel C, Wenzel M, Chierigo F et al. External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients. Int. J. Urol. 2022; 29: 17-24.
1. Zlotta AR, Egawa S, Pushkar D et al. Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men. J. Natl. Cancer Inst. 2013; 105: 1050-8.
1. Suzuki H, Akakura K, Komiya A et al. CAG polymorphic repeat lengths in androgen receptor gene among Japanese prostate cancer patients: potential predictor of prognosis after endocrine therapy. Prostate 2002; 51: 219-24.
1. Cooperberg MR, Hinotsu S, Namiki M et al. Trans-Pacific variation in outcomes for men treated with primary androgen-deprivation therapy (ADT) for prostate cancer. BJU Int. 2016; 117: 102-9.